American International Group’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-30,629
Closed -$1.29M 548
2024
Q1
$1.29M Buy
30,629
+7,535
+33% +$316K ﹤0.01% 1180
2023
Q4
$916K Sell
23,094
-93
-0.4% -$3.69K ﹤0.01% 1343
2023
Q3
$638K Buy
23,187
+824
+4% +$22.7K ﹤0.01% 1463
2023
Q2
$759K Buy
22,363
+245
+1% +$8.31K ﹤0.01% 1396
2023
Q1
$796K Buy
22,118
+441
+2% +$15.9K 0.01% 1336
2022
Q4
$966K Sell
21,677
-79
-0.4% -$3.52K 0.01% 1229
2022
Q3
$612K Buy
21,756
+307
+1% +$8.64K ﹤0.01% 1452
2022
Q2
$578K Sell
21,449
-1,382
-6% -$37.2K ﹤0.01% 1513
2022
Q1
$778K Sell
22,831
-1,607
-7% -$54.8K ﹤0.01% 1484
2021
Q4
$944K Sell
24,438
-731
-3% -$28.2K ﹤0.01% 1467
2021
Q3
$1.36M Buy
25,169
+3,199
+15% +$173K 0.01% 1257
2021
Q2
$735 Buy
+21,970
New +$735 ﹤0.01% 1690
2018
Q2
Sell
-5,606
Closed -$196K 3086
2018
Q1
$196K Sell
5,606
-302
-5% -$10.6K ﹤0.01% 2270
2017
Q4
$252K Buy
5,908
+499
+9% +$21.3K ﹤0.01% 2185
2017
Q3
$232K Buy
5,409
+404
+8% +$17.3K ﹤0.01% 2212
2017
Q2
$185K Buy
5,005
+1,082
+28% +$40K ﹤0.01% 2317
2017
Q1
$212K Buy
3,923
+259
+7% +$14K ﹤0.01% 2147
2016
Q4
$195K Sell
3,664
-9
-0.2% -$479 ﹤0.01% 2188
2016
Q3
$223K Buy
3,673
+5
+0.1% +$303 ﹤0.01% 2096
2016
Q2
$242K Sell
3,668
-407
-10% -$26.8K ﹤0.01% 2010
2016
Q1
$231K Sell
4,075
-13
-0.3% -$737 ﹤0.01% 2642
2015
Q4
$961K Buy
4,088
+82
+2% +$19.3K ﹤0.01% 1538
2015
Q3
$634K Sell
4,006
-12
-0.3% -$1.9K ﹤0.01% 1808
2015
Q2
$1.52M Buy
4,018
+93
+2% +$35.2K 0.01% 1293
2015
Q1
$1.64M Buy
3,925
+55
+1% +$23K 0.01% 1279
2014
Q4
$1.06M Sell
3,870
-155
-4% -$42.4K ﹤0.01% 1528
2014
Q3
$782K Buy
4,025
+37
+0.9% +$7.19K ﹤0.01% 1751
2014
Q2
$976K Sell
3,988
-100
-2% -$24.5K ﹤0.01% 1604
2014
Q1
$1.08M Buy
4,088
+98
+2% +$26K 0.01% 1465
2013
Q4
$1.45M Buy
3,990
+255
+7% +$92.6K 0.01% 1231
2013
Q3
$1.99M Buy
3,735
+34
+0.9% +$18.1K 0.01% 1047
2013
Q2
$867K Buy
+3,701
New +$867K 0.01% 1464